A Study of Patients With HER2-Positive Metastatic Breast Cancer
This is a prospective observational cohort study designed to describe effectiveness and safety (treatment outcomes and clinically significant cardiac adverse events, respectively) in patients with HER2-positive metastatic breast cancer.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00105456
|Study Director:||Isaiah Dimery, M.D.||Genentech, Inc.|